Doximity, Inc. (DOCS)
NYSE: DOCS · Real-Time Price · USD
45.93
-5.38 (-10.49%)
At close: Dec 5, 2025, 4:00 PM EST
46.10
+0.17 (0.37%)
After-hours: Dec 5, 2025, 7:59 PM EST

Company Description

Doximity, Inc. operates as a digital platform for medical professionals in the United States.

Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits.

The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems.

The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010.

Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Doximity, Inc.
Doximity logo
Country United States
Founded 2010
IPO Date Jun 24, 2021
Industry Health Information Services
Sector Healthcare
Employees 830
CEO Jeffrey Tangney

Contact Details

Address:
500 3rd Street, Suite 510
San Francisco, California 94107
United States
Phone 650 549 4330
Website doximity.com

Stock Details

Ticker Symbol DOCS
Exchange NYSE
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year April - March
Reporting Currency USD
IPO Price $26.00
CIK Code 0001516513
CUSIP Number 26622P107
ISIN Number US26622P1075
Employer ID 27-2485512
SIC Code 7371

Key Executives

Name Position
Jeffrey A. Tangney Co-Founder, Chief Executive Officer and Chairperson
Dr. Nathan Gross M.D. Advisor and Co-Founder
Anna Bryson Chief Financial Officer
Shari Buck Co-founder and SVice President People and Ops
Jey Balachandran Chief Technology Officer
Perry Scott Gold Head of Investor Relations
John Vaughan General Counsel, Corporate Secretary and Chief Compliance Officer
Bruno Miranda Senior Vice President of Engineering
Joel Davis Senior Vice President of Product
Ben Greenberg Senior Vice President and GM Commercial Products

Latest SEC Filings

Date Type Title
Dec 1, 2025 144 Filing
Nov 21, 2025 144 Filing
Nov 6, 2025 10-Q Quarterly Report
Nov 6, 2025 8-K Current Report
Nov 5, 2025 SCHEDULE 13G/A Filing
Nov 3, 2025 144 Filing
Oct 10, 2025 144 Filing
Oct 1, 2025 144 Filing
Sep 24, 2025 144 Filing
Sep 12, 2025 144 Filing